Abstract:Aim Nogo extracellular peptide 1-40 (NEP1-40), a Nogo-66 antagonistic peptide, is one of the potential candidates for therapeutic intervention after central nervous system injury. This study is focused on the generation of TAT-NEP1-40 fusion protein and its transducible effects and biological activity. Methods TAT-NEP1-40 fusion protein was expressed in vitro. Transducible effects of TAT-NEP1-40 were analyzed by using immunofluorescence staining or Western blot in vitro and in vivo. The biological activity of TAT-NEP1-40 was assessed by its effects against oxygen and glucose deprivation (OGD)-induced PC12 cell damages. Results Our results showed that the TAT-NEP1-40 fusion protein was successfully expressed, purified, and refolded. Western blot analysis and immunofluorescence staining confirmed the delivery of TAT-NEP1-40 protein into PC12 cells and rat brains. OGD caused cell apoptosis or death, decreased cell viability, increased lactate dehydrogenase release in medium and the Bax/Bcl-2 ratio, all of which were prevented by the TAT-NEP1-40 fusion proteins when added exogenously to culture medium. In addition, TAT-NEP1-40 promoted neurite outgrowth of PC12 cells exposed to OGD. Conclusion These results demonstrate that the TAT-NEP1-40 can be successfully generated and efficiently transduced into PC12 cells and rat brains. The TAT-NEP1-40 can protect PC12 cells against OGD and promote neurite outgrowth. This finding suggests that the transducible TAT-NEP1-40 fusion protein offers a possibility of the development of novel therapy for cerebral injuries via delivery of the biologically active TAT-NEP1-40 fusion protein into injured sites.

Prokaryotic Expression of pTAT-HA-ARC and pTAT-HA-eGFP and Indentification of Neuronal Transduction Activities

Expression of TAT-EGFP fusion protein and its transduction activity into PC12 cells

HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors.

[Constructing the Recombinant of Pet28a-Tat-lacz].

Construction of Vector Ptat-Bdnf and Expression of Fusion Protein

Construction and Expression of TAT-EGFP Fusion Protein Expression Vector

TAT Protein Transduction Domain Mediates Transmembrane Delivery of EGFP into Tissue Cells of Mice in Vivo

Construction and Expression of TAT-NDPK-A Protein and Its Penetration into the Cells

HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors11The nucleotide sequences of vectors pETAT-1/2/11/12, pNB-3/13, pHis-TAT-GFP, pHis-TAT-m-GFP and pHis-GFP have been deposited in GenBank under accession numbers AF525441–525449.

Expression and Bioactive of TAT-NPY Fusion Protein

Prokaryotic Expression of Fusion Protein Gene GST-TAT-GFP and Optimization of the Expression Conditions

Cloning,expression and activity anaylsis of cell-penetrating peptide TAT

Construction of Plasmid Vector with Tat and the Study of Its Ability Transduct Fusion Protein into Cells

Construction, expression, purification and neuroprotective activity of TAT-FGF21 fusion protein

Possible Mecanism of Transmembrane of TAT-PTD Fusion Protein

Expression, Purification and Transduction Activity Identification of TAT-NEP1-40

TAT-Mediated Protein Transduction of Nogo Extracellular Peptide 1-40 and Its Biological Activity

Construction of expression vector for ABAD-DP fusion gene

Expression and Purification of Angiogenin-Egfp Fusion Protein in E.coli

Purification,Expression and Verification of PTD-Lmp-3 Fusion Protein

Construction, Expression and Activity Assay of A Novel Cell Penetrating Peptide